Cytokinetics plans to take Lou Gehrig's disease drug into late-stage study

Cytokinetics Inc. plans to take an experimental drug into late-stage human studies for patients with the strength-robbing disease known as Lou Gehrig's disease despite conflicting data from an earlier study...